University of Queensland BSc/BMus, PGDipSc
University of NSW PhD
Knownfor
Research to develop cell and gene therapies and identify therapeutic targets for Friedreich ataxia
Medical career
Profession
Molecular Biologist
Institutions
Murdoch Children's Research Institute &
Department of Paediatrics, The University of Melbourne
Research
Gene therapy and neurodegenerative diseases.
Marguerite Virginia Evans-GaleaAM is the co-founder of Women in STEMM Australia. STEMM (science, technology, engineering, maths and medicine). Her research is focused on gene therapy and neurodegenerative diseases.
Evans-Galea grew up in Mackay, Queensland. She was raised by her mother after her parents separated.[1]:2:20 mins In High School she learned clarinet and discovered classical music. After school she planned to be a music therapist, but she was "bitten by the science bug" in her third year of university.[1]:3:50 mins
In 1994 she graduated with a double degree from the University of Queensland BSc/BMus. This was followed by a PGDipSc (Postgraduate Diploma in Science) in 1995 also from the University of Queensland and a PhD from the University of New South Wales in 1999.[2] Her doctoral thesis in molecular biology was titled Characterisation of the response to lipid hydroperoxide stress of the yeast Saccharomyces cerevisiae.[3]
On her return to Australia in 2008 Evans-Galea joined a clinical team at the Bruce Lefroy Centre for Genetic Health Research at the Murdoch Children's Research Institute (MCRI)[5] that allowed her to connect her research on yeasts with medical research. She develops cell and gene therapies for Friedreich's ataxia a neurodegenerative disease which affects children from around 10 years of age.[6]
Marguerite Evans-Galea leads "Next Generation Technologies" panel at CeBIT
She was an Honorary research scientist at the Murdoch Children's Research Institute in 2008[6] and Honorary Fellow, Department of Paediatrics, The University of Melbourne since 2009.[2][7]
She served on the Immune Responses Committee of the American Society for Gene and Cell Therapy and is a past member of the executive committee of the Australasian Gene and Cell Therapy Society.[6]
Evans-Galea helps early researchers and she is a leading advocate of gender equality.[9] She developed graduate mentoring programs in the USA.[10] and was the founding chair of the Early-Mid Career Researcher (EMCR) Forum with the Australian Academy of Science from 2011 to 2013.[11] She is a committee member of the Expert Advisory Group of the Science in Australia Gender Equity (SAGE) Forum.[12]
She is Executive Director of the Industry Mentoring Network in STEM (IMNIS) at the Australian Academy of Technology and Engineering.[10] IMNIS connects motivated PhD students in science, technology, engineering and mathematics with high level industry mentors for a one-year industry mentoring program.[13] In October 2018 about 300 PhD mentees were involved in the MTP (medical technologies, biotechnology and pharmaceutical) program in five states and 17 organisations.[14]
Evans-Galea is Program Coordinator for the IMNIS Energy-Minerals Programs and the CCRM Australia-IMNIS International Mentoring Pilot internationally. She is co-founder of Women in STEMM Australia.[10]
Evans-Galea was appointed a Member of the Order of Australia in recognition of her service to women in STEMM.[15]
Awards and honours
2006 — Travel Award, American Society of Gene and Cell Therapy, USA[6]
2009 — New Investigator Award, Friedreich Ataxia Research Alliance, USA[16]
2009 — Panos Ioannou Young Investigator Award, Australasian Gene and Cell Therapy Society[5]
↑Evans-Galea, M. E. (1998). Characterisation of the response to lipid hydroperoxide stress of the yeast Saccharomyces cerevisiae. PhD thesis. University of NSW.